BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 9183663)

  • 1. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
    Drexler HG; Zaborski M; Quentmeier H
    Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.
    Souyri M
    Semin Hematol; 1998 Jul; 35(3):222-31. PubMed ID: 9685168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Ikeda H; Ishikawa J; Yoshida H; Horikawa Y; Nishiura T; Tahara T; Kato T; Miyazaki H; Matsuzawa Y
    Leukemia; 1996 Jan; 10(1):91-4. PubMed ID: 8558944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines.
    Graf G; Dehmel U; Drexler HG
    Leuk Res; 1996 Oct; 20(10):831-8. PubMed ID: 8960108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells.
    Matsumura I; Ikeda H; Kanakura Y
    Leuk Lymphoma; 1996 Nov; 23(5-6):533-8. PubMed ID: 9031083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
    Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
    Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the MPL receptor in myeloproliferative disorders.
    Kaushansky K
    Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia.
    Hirai H; Shimazaki C; Yamagata N; Goto H; Inaba T; Kikuta T; Sumikuma T; Sudo Y; Ashihara E; Fujita N; Hibi S; Imashuku S; Ito E; Nakagawa M
    Eur J Haematol; 1997 Jul; 59(1):38-46. PubMed ID: 9260579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells.
    Matsumura I; Kanakura Y; Kato T; Ikeda H; Horikawa Y; Ishikawa J; Kitayama H; Nishiura T; Tomiyama Y; Miyazaki H; Matsuzawa Y
    Blood; 1996 Oct; 88(8):3074-82. PubMed ID: 8874206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin receptor expression in human cancer cell lines and primary tissues.
    Columbyova L; Loda M; Scadden DT
    Cancer Res; 1995 Aug; 55(16):3509-12. PubMed ID: 7627956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
    Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
    Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.